Coherus Biosciences
Latest round
- Series C
Last raised
- May 2014
Total raised
- $60M
Investors
- 9
About Coherus Biosciences
Founded in 2010, Coherus Biosciences, Inc. is dedicated to developing cancer therapies.00 mn. The headquarters is located in Redwood City, California, and the firm has made notable strides in its business strategy over the years, concentrating on immuno-oncology. The CEO and founder's history are not explicitly stated, but the company has shown a consistent focus on advancing its therapeutic offerings. Coherus Oncology develops and commercializes immuno-oncology therapies that enhance treatment outcomes for patients with difficult cancer types. Their flagship product, LOQTORZI® (toripalimab-tpzi), is the only FDA-approved therapy for recurrent or metastatic nasopharyngeal carcinoma (NPC), offered as a standalone or in combination with chemotherapy. The pipeline includes several clinical-stage candidates designed to target the tumor microenvironment, with ongoing trials to evaluate their efficacy against various cancers. The company primarily serves healthcare providers and institutions across the United States and select international markets, emphasizing innovative solutions for patients.96 mn. The company’s revenue primarily comes from the commercialization of its proprietary therapies, particularly LOQTORZI®, sold directly to healthcare facilities and specialists in cancer treatment. The pricing for LOQTORZI® and investigational therapies is shaped by market dynamics and healthcare reimbursement systems, ensuring access for patients in need. The company is focused on launching new products, enhancing its pipeline for new therapy candidates, and expanding into additional markets.
Who invested in Coherus Biosciences
9 investors across 2 rounds
See all investors in Coherus Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Coherus Biosciences
Who invested in Coherus Biosciences?
Coherus Biosciences has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Coherus Biosciences raised?
Coherus Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Coherus Biosciences last raise money?
Coherus Biosciences's most recent round on record is a Series C, in May 2014.
What does Coherus Biosciences do?
Founded in 2010, Coherus Biosciences, Inc.
Where is Coherus Biosciences headquartered?
Coherus Biosciences is headquartered in Redwood City, US.
Which VCs invest in companies like Coherus Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Coherus Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Coherus Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.